Previous Close | 4.50 |
Open | 5.20 |
Bid | 5.85 |
Ask | 6.05 |
Strike | 240.00 |
Expire Date | 2025-01-17 |
Day's Range | 5.20 - 5.60 |
Contract Range | N/A |
Volume | |
Open Interest | 509 |
An FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to target the WHO-recommended JN.1 variant or the KP.2 variant which is the currently dominating strain in the country.
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Moderna, Inc. (NASDAQ:MRNA) is the top gene therapy stock to invest in now. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]